批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/05/01 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/08/25 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/30 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/03/28 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/01/22 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
2013/01/22 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/09/29 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/12/04 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/06/09 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/04/07 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/08/05 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/08/30 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/05/27 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/25 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/12/04 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/10/17 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/05/01 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/04/10 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/05/03 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/04/17 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/11/19 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/09/23 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/02/01 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/02/11 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/02/11 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/10/20 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/03/19 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/05/15 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/02/13 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMOXICILLIN; CLAVULANATE POTASSIUM 剂型/给药途径:TABLET;ORAL 规格:875MG;EQ 125MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050720 |
001 |
NDA |
AUGMENTIN '875' |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
Yes |
No |
AB |
1996/02/13
|
US ANTIBIOTICS |
065063 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
Yes |
AB |
2002/03/14
|
SANDOZ |
065096 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2002/10/29
|
TEVA PHARMS USA |
065093 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2002/11/21
|
SANDOZ INC |
091568 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2012/01/20
|
AUROBINDO PHARMA LTD |
203824 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2016/08/23
|
HIKMA PHARMS |
204755 |
003 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2016/12/30
|
MICRO LABS LTD INDIA |
209991 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
TABLET;ORAL |
875MG;EQ 125MG BASE |
Prescription |
No |
No |
AB |
2023/09/15
|
DEVA HOLDING AS |